Transfusion support for a patient with alloanti-D and the RHD*DV.1 allele.

[1]  C. Westhoff,et al.  Red Cell Antigens and Antibodies. , 2022, Hematology/oncology clinics of North America.

[2]  Ji He,et al.  The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals , 2021, Frontiers in Immunology.

[3]  G. Mishra,et al.  Molecular characterization of RhD variant phenotypes among blood donors: A study from the coastal region of India. , 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[4]  Xiaohong Cai,et al.  2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests , 2021, Hematology.

[5]  Hui Liu,et al.  Quantitative determination of agglutination based on the automatic hematology analyzer and the clinical significance of the erythrocyte-specific antibody. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[6]  J. Bordin,et al.  RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen. , 2020, Blood transfusion = Trasfusione del sangue.

[7]  H. Hsiao,et al.  Manual polybrene method for pretransfusion test could overcome the interference of daratumumab therapy in myeloma , 2019, Transfusion.

[8]  J. Hendrickson,et al.  Transfusion-related red blood cell alloantibodies: induction and consequences. , 2019, Blood.

[9]  J. Bingulac-Popović,et al.  Anti‐D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population , 2018, Journal of clinical laboratory analysis.

[10]  Seong-Wook Lee,et al.  Genotyping of 19 red cell antigens, including RHD, using liquid bead arrays. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[11]  Y. Liew,et al.  A D+ blood donor with a novel RHD*D‐CE(5‐6)‐D gene variant exhibits the low‐frequency antigen RH23 (DW) characteristic of the partial DVa phenotype , 2016, Transfusion.

[12]  D. Wouters,et al.  Lyse or not to lyse: Clinical significance of red blood cell autoantibodies. , 2015, Blood reviews.

[13]  J. Guerrero,et al.  Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[14]  Ji He,et al.  [Molecular basis of partial D phenotypes in Chinese]. , 2006, Zhongguo shi yan xue ye xue za zhi.

[15]  W. Flegel,et al.  Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti‐D alloimmunization and prevention , 2005, Transfusion.

[16]  Wei Wang,et al.  Whole exon 5 and intron 5 replaced by RHCE in DVa(Hus) , 2004, Journal of Human Genetics.

[17]  M. Uchikawa,et al.  DVa Category Phenotype and Genotype in Japanese Families , 2000, Vox Sanguinis.

[18]  S. Kōzuma,et al.  Polymorphisms of RhDVa and a New RhDVa–Like Variant Found in Japanese Individuals , 2000, Vox Sanguinis.

[19]  T. Omi,et al.  Detection of Rh23 in the partial D phenotype associated with the DVa category , 2000, Transfusion.

[20]  T. Omi,et al.  The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype. , 1999, Biochemical and biophysical research communications.

[21]  K. Wong,et al.  Hemolytic transfusion reaction due to Rh antibodies detectable only by manual polybrene and polyethylene glycol technique. , 1995, American journal of clinical pathology.

[22]  J. Cartron,et al.  Transcript analysis of D category phenotypes predicts hybrid Rh D-CE-D proteins associated with alteration of D epitopes. , 1995, Blood.

[23]  R. Farrar,et al.  Anti‐Jka, ‐C, and ‐E in a single patient, initially demonstrable only by the manual hexadimethrine bromide (Polybrene) test, with incompatibilities confirmed by 51Cr‐labeled red cell studies , 1988, Transfusion.

[24]  E. L. Snyder,et al.  Hemolytic Anti‐hr” (e) Detectable Solely by an Automated Polybrene Technique , 1978, Transfusion.